Register
Draft Guidance on the inclusion of pregnant women in clinical trials |
Journal Updates
eMediNexus Coverage from: 
Draft Guidance on the inclusion of pregnant women in clinical trials
eMediNexus,  16 April 2018
remove_red_eye 522 Views
#Business And Medicine #Obstetrics and Gynecology #Pharmacist


comment                   
        



The US Food and Drug Administration (FDA) has issued draft guidance for industry “Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials” about how and when to include pregnant women in clinical trials for drugs and therapeutic biological products on March 27, 2018. The draft is open for comments and suggestions.


Comments

Comments on eMediNexus are moderated. We retain the right to remove any comments at our sole discretion.